drugset / Trial / NCT07264192
A Study of HS-10518 in Healthy Adult Premenopausal Females in China
Phase 1
Completed
60 enrolled
West China Second University Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HS-10518 in healthy adult premenopausal females in China
Timeline
- Start
- 2025-03-11
- Primary completion
- 2025-06-23
- Completion
- 2025-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10518 | Unknown | 10 mg | Oral |
| Subject | HS-10518 | Unknown | 20 mg | Oral |
| Subject | HS-10518 | Unknown | 40 mg | Oral |
| Subject | HS-10518 | Unknown | 80 mg | Oral |